Search Results - "Laverty, Emily A."

Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models by Brockman, Qierra R., Scherer, Amanda, McGivney, Gavin R., Gutierrez, Wade R., Rytlewski, Jeffrey, Sheehan, Alexa, Warrier, Akshaya, Laverty, Emily A., Roughton, Grace, Carnevale, Nina C., Knepper-Adrian, Vickie, Dodd, Rebecca D.

“…CRISPR/Cas9 gene editing has evolved from a simple laboratory tool to a powerful method of in vivo genomic engineering. As the applications of CRISPR/Cas9…”
Get full text

Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models by Gutierrez, Wade R., Scherer, Amanda, McGivney, Gavin R., Brockman, Qierra R., Knepper-Adrian, Vickie, Laverty, Emily A., Roughton, Grace A., Dodd, Rebecca D.

“…Immune cells play critical functions in cancer, and mice with intact immune systems are vital to understanding tumor immunology. Both genetically engineered…”
Get full text

PRC2 loss drives MPNST metastasis and matrix remodeling by Brockman, Qierra R, Scherer, Amanda, McGivney, Gavin R, Gutierrez, Wade R, Voigt, Andrew P, Isaacson, Alexandra L, Laverty, Emily A, Roughton, Grace, Knepper-Adrian, Vickie, Darbro, Benjamin, Tanas, Munir R, Stipp, Christopher S, Dodd, Rebecca D

“…The histone methyltransferase PRC2 plays a complex role in cancer. Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with frequent…”
Get full text

Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism by Gutierrez, Wade R, Scherer, Amanda, Rytlewski, Jeffrey D, Laverty, Emily A, Sheehan, Alexa P, McGivney, Gavin R, Brockman, Qierra R, Knepper-Adrian, Vickie, Roughton, Grace A, Quelle, Dawn E, Gordon, David J, Monga, Varun, Dodd, Rebecca D

“…The DNA methyltransferase inhibitor decitabine has classically been used to reactivate silenced genes and as a pretreatment for anticancer therapies. In a…”
Get full text

Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in Pten -deleted Mouse Models of Sarcoma by Dodd, Rebecca D, Scherer, Amanda, Huang, Wesley, McGivney, Gavin R, Gutierrez, Wade R, Laverty, Emily A, Ashcraft, Kathleen A, Stephens, Victoria R, Yousefpour, Parisa, Saha, Soumen, Knepper-Adrian, Vickie, Floyd, Warren, Chen, Mark, Ma, Yan, Mastria, Eric M, Cardona, Diana M, Eward, William C, Chilkoti, Ashutosh, Kirsch, David G

“…Nanoparticle-encapsulated drug formulations can improve responses to conventional chemotherapy by increasing drug retention within the tumor and by promoting a…”
Get full text

Distinct Tumor Microenvironments Are a Defining Feature of Strain-Specific CRISPR/Cas9-Induced MPNSTs by Scherer, Amanda, Stephens, Victoria R, McGivney, Gavin R, Gutierrez, Wade R, Laverty, Emily A, Knepper-Adrian, Vickie, Dodd, Rebecca D

“…The tumor microenvironment plays important roles in cancer biology, but genetic backgrounds of mouse models can complicate interpretation of tumor phenotypes…”
Get full text

Abstract A024: PRC2 loss drives MPNST metastasis and matrix remodeling by Brockman, Qierra R., Scherer, Amanda, McGivney, Gavin R., Gutierrez, Wade R., Voigt, Andrew, Isaacson, Alexandra, Laverty, Emily A., Roughton, Grace, Knepper-Adrian, Vickie, Darbro, Benjamin, Tanas, Munir R., Stipp, Christopher, Dodd, Rebecca D.

“…Epigenetic reprogramming alters gene transcription in response to different cellular cues and can occur at both the DNA level as well as histone…”
Get full text